Compass Therapeutics, Inc. (CMPX)

Compass Therapeutics Statistics

Total Valuation

CMPX has a market cap or net worth of $277.26 million. The enterprise value is $145.42 million.

Market Cap	277.26M
Enterprise Value	145.42M

Important Dates

The last earnings date was Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

CMPX has 138.28 million shares outstanding. The number of shares has increased by 6.33% in one year.

Current Share Class	138.28M
Shares Outstanding	138.28M
Shares Change (YoY)	+6.33%
Shares Change (QoQ)	+1.18%
Owned by Insiders (%)	6.79%
Owned by Institutions (%)	42.73%
Float	88.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	295.07
Forward PS	n/a
PB Ratio	2.28
P/TBV Ratio	2.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	171.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.33, with a Debt / Equity ratio of 0.06.

Current Ratio	8.33
Quick Ratio	7.56
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -41.31% and return on invested capital (ROIC) is -28.09%.

Return on Equity (ROE)	-41.31%
Return on Assets (ROA)	-26.41%
Return on Invested Capital (ROIC)	-28.09%
Return on Capital Employed (ROCE)	-53.04%
Revenue Per Employee	$24,286
Profits Per Employee	-$1.58M
Employee Count	35
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.63% in the last 52 weeks. The beta is 1.19, so CMPX's price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	+25.63%
50-Day Moving Average	2.04
200-Day Moving Average	1.91
Relative Strength Index (RSI)	54.80
Average Volume (20 Days)	808,820

Short Selling Information

The latest short interest is 7.63 million, so 5.52% of the outstanding shares have been sold short.

Short Interest	7.63M
Short Previous Month	8.17M
Short % of Shares Out	5.52%
Short % of Float	8.59%
Short Ratio (days to cover)	3.02

Income Statement

In the last 12 months, CMPX had revenue of $850,000 and -$55.22 million in losses. Loss per share was -$0.40.

Revenue	850,000
Gross Profit	850,000
Operating Income	-61.82M
Pretax Income	-47.24M
Net Income	-55.22M
EBITDA	-61.25M
EBIT	-61.82M
Loss Per Share	-$0.40

Balance Sheet

The company has $112.64 million in cash and $6.38 million in debt, giving a net cash position of $106.25 million or $0.77 per share.

Cash & Cash Equivalents	112.64M
Total Debt	6.38M
Net Cash	106.25M
Net Cash Per Share	$0.77
Equity (Book Value)	110.28M
Book Value Per Share	0.80
Working Capital	109.25M

Cash Flow

In the last 12 months, operating cash flow was -$44.18 million and capital expenditures -$62,000, giving a free cash flow of -$44.24 million.

Operating Cash Flow	-44.18M
Capital Expenditures	-62,000
Free Cash Flow	-44.24M
FCF Per Share	-$0.32

Margins

Gross Margin	100.00%
Operating Margin	-7,273.06%
Pretax Margin	-6,496.59%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMPX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.33%
Shareholder Yield	-6.33%
Earnings Yield	-21.94%
FCF Yield	-17.58%

Analyst Forecast

The average price target for CMPX is $13.13, which is 554.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.13
Price Target Difference	554.86%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	241.39%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CMPX has an Altman Z-Score of 2.19 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.19
Piotroski F-Score	1